About Parnax Lab Limited
Data last updated: 31 December 2025
Parnax Lab Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 03 August 1982, the company has been in operation for over 44 years.
Registered with ROC Mumbai under CIN L36912MH1982PLC027925. Listed on BSE: 506128.
Capital: an authorised share capital of ₹13 Cr and a paid-up capital of ₹11.49 Cr. Formerly known as Krishna-Deep Trade and Investment Ltd. It is led by directors including Vijaykumar Shivaji Ayare and Harish Sunderlal Panpalia.
Last AGM: 29 September 2025. Financial statements filed for year ended 31 March 2025. Office: Gala No. 114 Bldg. No. 8 Jogani Industrial Complex Chunabhatti, Mumbai, Maharashtra, India – 400022.
As per the financials filed for FY 2025, the company reported a revenue of ₹189.41 Cr, a growth of 0% compared to the previous year.
Its group structure includes 1 subsidiary.
The company is associated with 1 brand - Naxpar Group. As per MCA filings, the company has open charges of ₹24.2 Cr and satisfied charges of ₹4.66 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website naxparlab.com.
-
Email*****@*****.com
-
Telephone**************
-
Website
-
Social Media**************
-
Registered AddressGala No. 114 Bldg. No. 8 Jogani Industrial Complex Chunabhatti, Mumbai, Maharashtra, India – 400022
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Parnax Lab Limited
Parnax Lab Limited has one previous CIN (Corporate Identification Number): L67120MH1982PLC027925. The current CIN is L36912MH1982PLC027925, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L36912MH1982PLC027925 | Current |
| L67120MH1982PLC027925 | Previous |
Associated Brands with Parnax Lab Limited
Parnax Lab Limited operates one associated brand: Naxpar Group. These brands represent Parnax Lab Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical, cosmetic, herbal, and nutraceutical formulations are manufactured. | naxparlab.com |
Business Activity of Parnax Lab Limited
Parnax Lab Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Parnax Lab Limited
Parnax Lab Limited is audited by M/s C N Patel & Co. (ICAI peer reviewed, certificate valid till 2027-05-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| M/s C N Patel & Co. (ICAI peer reviewed, certificate valid till 2027-05-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Parnax Lab Limited
Parnax Lab Limited is currently managed by 10 directors, with 21 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Vijaykumar Shivaji Ayare
Also directs:
Wanbury Pharma Limited
|
Director | 10 Feb 2025 | 1 Years 4 Months | Current |
|
Harish Sunderlal Panpalia
Also directs:
Naxpar Pharma Private Limited
|
Director | 11 Aug 2023 | 2 Years 10 Months | Current |
|
Mihir Prakash Shah
Also directs:
Novomed Pharma Pvt. Ltd, Naxpar Pharma Private Limited
|
Ceo | 05 Jul 2024 | 2 Years 0 Months | Current |
|
Yogesh Kantilal Varia
Also directs:
Naxpar Pharma Private Limited
|
Director | 28 May 2021 | 5 Years 1 Months | Current |
| Tirunillai Venkateswara Anatharaman | Director | 31 Mar 2015 | 11 Years 3 Months | Current |
| Binoy Baiju Shah | Cfo | 05 Jul 2024 | 2 Years 0 Months | Current |
Financials of Parnax Lab Limited FY 2026 filings available
Parnax Lab Limited reported revenue of ₹248.54 Cr (up 32.39% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹248.54 Cr | ₹187.74 Cr | ₹188.71 Cr | ₹167.61 Cr | ₹163.03 Cr | ₹89.52 Cr | ₹95.31 Cr | ₹108.78 Cr |
| Other Income | ₹3.78 Cr | ₹1.68 Cr | ₹81.57 Lakh | ₹77.22 Lakh | ₹32.97 Lakh | ₹21.03 Lakh | ₹66.23 Lakh | ₹2.11 Cr |
| Total Income | ₹252.33 Cr | ₹189.41 Cr | ₹189.53 Cr | ₹168.38 Cr | ₹163.36 Cr | ₹89.73 Cr | ₹95.98 Cr | ₹110.89 Cr |
| Cost of Materials Consumed | ₹148.74 Cr | ₹93.85 Cr | ₹104.74 Cr | ₹88.41 Cr | ₹91.13 Cr | ₹40.41 Cr | ₹45.3 Cr | ₹43.92 Cr |
| Purchases of Stock-in-Trade | ₹33.7 Lakh | ₹46.42 Lakh | ₹15.02 Lakh | ₹93.88 Lakh | ₹17.11 Lakh | ₹36.28 Lakh | ₹87.97 Lakh | ₹9.02 Cr |
| Changes in Inventories | -₹1.99 Cr | ₹1.69 Cr | -₹2.07 Cr | -₹53.37 Lakh | -₹1.66 Cr | ₹44.75 Lakh | -₹90.34 Lakh | -₹22.08 Lakh |
| Employee Benefit Expense | ₹27.13 Cr | ₹24.43 Cr | ₹23.72 Cr | ₹20.05 Cr | ₹17.43 Cr | ₹13.68 Cr | ₹14.08 Cr | ₹13.06 Cr |
| Finance Costs | ₹5.71 Cr | ₹5.39 Cr | ₹5.35 Cr | ₹4.95 Cr | ₹5.23 Cr | ₹5.08 Cr | ₹4.6 Cr | ₹3.89 Cr |
| Depreciation & Amortisation | ₹8.05 Cr | ₹7.38 Cr | ₹6.96 Cr | ₹6.53 Cr | ₹5.87 Cr | ₹5.16 Cr | ₹4.46 Cr | ₹3.82 Cr |
| Other Expenses | ₹47.07 Cr | ₹40.54 Cr | ₹38.63 Cr | ₹35.75 Cr | ₹32.93 Cr | ₹24.67 Cr | ₹29.53 Cr | ₹32.78 Cr |
| Total Expenses | ₹235.05 Cr | ₹173.74 Cr | ₹177.48 Cr | ₹156.1 Cr | ₹151.1 Cr | ₹89.81 Cr | ₹97.94 Cr | ₹106.27 Cr |
| Profit Before Exceptional Items & Tax | ₹17.28 Cr | ₹15.67 Cr | ₹12.05 Cr | ₹12.28 Cr | ₹12.26 Cr | -₹8.38 Lakh | -₹1.97 Cr | ₹4.62 Cr |
| Exceptional Items | -₹1.37 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹15.91 Cr | ₹15.67 Cr | ₹12.05 Cr | ₹12.28 Cr | ₹12.26 Cr | -₹8.38 Lakh | -₹1.97 Cr | ₹4.62 Cr |
| Total Tax Expense | ₹4.11 Cr | ₹4.13 Cr | ₹2.76 Cr | ₹3.84 Cr | ₹4.01 Cr | ₹27.69 Lakh | ₹94.88 Lakh | ₹1.31 Cr |
| Net Profit | ₹11.8 Cr | ₹11.54 Cr | ₹9.29 Cr | ₹8.63 Cr | ₹8.26 Cr | -₹36.07 Lakh | -₹2.92 Cr | ₹3.31 Cr |
| attributable to Owners | ₹11.78 Cr | ₹11.52 Cr | ₹9.61 Cr | ₹8.62 Cr | ₹8.24 Cr | -₹36.22 Lakh | -₹2.91 Cr | ₹3.3 Cr |
| attributable to NCI | ₹2.18 Lakh | ₹2.03 Lakh | ₹1.56 Lakh | ₹1.49 Lakh | ₹1.54 Lakh | ₹15,000 | -₹18,000 | ₹66,000 |
| Other Comprehensive Income | ₹25.96 Lakh | ₹76,000 | -₹19.1 Lakh | -₹10.14 Lakh | -₹11.57 Lakh | ₹11.28 Lakh | -₹2.12 Lakh | -₹8 Lakh |
| Total Comprehensive Income | ₹12.06 Cr | ₹11.55 Cr | ₹9.1 Cr | ₹8.53 Cr | ₹8.14 Cr | -₹24.79 Lakh | -₹2.94 Cr | ₹3.23 Cr |
| EBITDA (computed) | ₹31.03 Cr | ₹28.44 Cr | ₹24.36 Cr | ₹23.76 Cr | ₹23.36 Cr | ₹10.16 Cr | ₹7.09 Cr | ₹12.33 Cr |
| Basic EPS | ₹10.27 | ₹10.05 | ₹8.38 | ₹7.80 | ₹9.70 | ₹-0.42 | ₹-3.43 | ₹3.89 |
| Diluted EPS | ₹10.27 | ₹10.05 | ₹8.38 | ₹7.80 | ₹9.70 | ₹-0.42 | ₹-3.43 | ₹3.89 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹227.63 Cr | ₹189.82 Cr | ₹188.77 Cr | ₹145.07 Cr | ₹154.09 Cr | ₹106.26 Cr | ₹107.14 Cr | ₹94.68 Cr |
| Non-current Assets | ₹134.59 Cr | ₹121.48 Cr | ₹113.33 Cr | ₹84.01 Cr | ₹78.7 Cr | ₹67.02 Cr | ₹61.53 Cr | ₹57.79 Cr |
| Current Assets | ₹90.69 Cr | ₹64.78 Cr | ₹71.81 Cr | ₹57.32 Cr | ₹71.65 Cr | ₹35.5 Cr | ₹41.87 Cr | ₹33.17 Cr |
| Property, Plant & Equipment | ₹114.05 Cr | ₹108.64 Cr | ₹79.39 Cr | ₹72.86 Cr | ₹71.86 Cr | ₹59.52 Cr | ₹57.47 Cr | ₹50.78 Cr |
| Inventories | ₹36.22 Cr | ₹25.77 Cr | ₹29.93 Cr | ₹21.69 Cr | ₹19.93 Cr | ₹10.79 Cr | ₹11.15 Cr | ₹8.47 Cr |
| Trade Receivables | ₹37.81 Cr | ₹30.76 Cr | ₹32.56 Cr | ₹27.89 Cr | ₹38.7 Cr | ₹16.71 Cr | ₹23.08 Cr | ₹19.18 Cr |
| Cash & Equivalents | ₹33.64 Lakh | ₹54.99 Lakh | ₹45.78 Lakh | ₹1.28 Cr | ₹4.36 Cr | ₹18.14 Lakh | ₹38.68 Lakh | -₹5.19 Lakh |
| Equity (Net Worth) | ₹95.3 Cr | ₹83.24 Cr | ₹71.69 Cr | ₹62.26 Cr | ₹48.28 Cr | ₹32.62 Cr | ₹32.87 Cr | ₹35.81 Cr |
| Equity Share Capital | ₹11.49 Cr | ₹11.49 Cr | ₹11.49 Cr | ₹11.49 Cr | ₹9.81 Cr | ₹8.5 Cr | ₹8.5 Cr | ₹8.5 Cr |
| Borrowings (Non-current) | ₹21.73 Cr | ₹17.99 Cr | ₹21.05 Cr | ₹12.02 Cr | ₹17.41 Cr | ₹13.98 Cr | ₹19.15 Cr | ₹21.58 Cr |
| Borrowings (Current) | ₹52.8 Cr | ₹42.65 Cr | ₹50.01 Cr | ₹38.88 Cr | ₹48.06 Cr | ₹36.43 Cr | ₹28.11 Cr | ₹15.69 Cr |
| Total Debt (computed) | ₹74.52 Cr | ₹60.64 Cr | ₹71.06 Cr | ₹50.9 Cr | ₹65.47 Cr | ₹50.41 Cr | ₹47.27 Cr | ₹37.27 Cr |
| Current Liabilities | ₹95.85 Cr | ₹74.33 Cr | ₹81.83 Cr | ₹63.04 Cr | ₹81.61 Cr | ₹54.37 Cr | ₹52.42 Cr | ₹36.29 Cr |
| Total Liabilities | ₹132.33 Cr | ₹106.58 Cr | ₹117.07 Cr | ₹82.81 Cr | ₹105.81 Cr | ₹73.64 Cr | ₹74.27 Cr | ₹58.87 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹8 Cr | ₹32.3 Cr | ₹15.88 Cr | ₹20.91 Cr | ₹8.55 Cr |
| Investing Cash Flow | -₹16.39 Cr | -₹16.39 Cr | -₹31.52 Cr | -₹9.92 Cr | -₹16.5 Cr |
| Financing Cash Flow | ₹8.18 Cr | -₹15.82 Cr | ₹14.82 Cr | -₹14.07 Cr | ₹12.13 Cr |
| Capital Expenditure | ₹17.31 Cr | ₹18.58 Cr | ₹32.42 Cr | ₹10.27 Cr | ₹16.26 Cr |
| Free Cash Flow (computed) | -₹9.31 Cr | ₹13.72 Cr | -₹16.54 Cr | ₹10.64 Cr | -₹7.71 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹21.35 Lakh | ₹9.21 Lakh | -₹82.18 Lakh | -₹3.08 Cr | ₹4.18 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹69.63 Cr | ₹62.94 Cr | ₹62.6 Cr | ₹53.38 Cr | ₹49.04 Cr | ₹40.22 Cr | ₹48.36 Cr | ₹50.12 Cr |
| Other Income | ₹1.99 Cr | ₹97.15 Lakh | ₹63.13 Lakh | ₹18.46 Lakh | ₹42.57 Lakh | ₹18.95 Lakh | ₹94.95 Lakh | ₹11.18 Lakh |
| Total Income | ₹71.62 Cr | ₹63.91 Cr | ₹63.23 Cr | ₹53.56 Cr | ₹49.46 Cr | ₹40.41 Cr | ₹49.31 Cr | ₹50.23 Cr |
| Cost of Materials Consumed | ₹43.76 Cr | ₹37.86 Cr | ₹34.82 Cr | ₹32.27 Cr | ₹25.74 Cr | ₹23.29 Cr | ₹21.52 Cr | ₹23.31 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹4.48 Lakh | ₹0 | ₹33.25 Lakh | ₹38.5 Lakh | ₹6.76 Lakh | ₹13.61 Lakh | ₹36.83 Lakh |
| Changes in Inventories | -₹30.66 Lakh | -₹56.78 Lakh | ₹1.5 Cr | -₹2.62 Cr | ₹16.11 Lakh | -₹1.79 Cr | ₹3 Cr | -₹17.29 Lakh |
| Employee Benefit Expense | ₹7.2 Cr | ₹7.1 Cr | ₹6.44 Cr | ₹6.39 Cr | ₹6.22 Cr | ₹5.67 Cr | ₹6.12 Cr | ₹6.42 Cr |
| Finance Costs | ₹1.61 Cr | ₹1.47 Cr | ₹1.4 Cr | ₹1.22 Cr | ₹1.28 Cr | ₹1.23 Cr | ₹1.38 Cr | ₹1.5 Cr |
| Depreciation & Amortisation | ₹2.04 Cr | ₹1.96 Cr | ₹2.1 Cr | ₹1.94 Cr | ₹1.83 Cr | ₹1.79 Cr | ₹1.94 Cr | ₹1.83 Cr |
| Other Expenses | ₹14.09 Cr | ₹11.66 Cr | ₹11.76 Cr | ₹9.57 Cr | ₹9.91 Cr | ₹8.71 Cr | ₹10.34 Cr | ₹11.58 Cr |
| Total Expenses | ₹68.39 Cr | ₹59.52 Cr | ₹58.03 Cr | ₹49.11 Cr | ₹45.51 Cr | ₹38.96 Cr | ₹44.44 Cr | ₹44.83 Cr |
| Profit Before Exceptional Items & Tax | ₹3.23 Cr | ₹4.39 Cr | ₹5.2 Cr | ₹4.46 Cr | ₹3.95 Cr | ₹1.45 Cr | ₹4.87 Cr | ₹5.4 Cr |
| Exceptional Items | -₹23.13 Lakh | -₹1.14 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹3 Cr | ₹3.25 Cr | ₹5.2 Cr | ₹4.46 Cr | ₹3.95 Cr | ₹1.45 Cr | ₹4.87 Cr | ₹5.4 Cr |
| Total Tax Expense | ₹81.38 Lakh | ₹53.29 Lakh | ₹1.58 Cr | ₹1.18 Cr | ₹1.03 Cr | ₹23.5 Lakh | ₹1.46 Cr | ₹1.42 Cr |
| Net Profit | ₹2.18 Cr | ₹2.72 Cr | ₹3.62 Cr | ₹3.27 Cr | ₹2.93 Cr | ₹1.21 Cr | ₹3.41 Cr | ₹3.99 Cr |
| attributable to Owners | ₹2.18 Cr | ₹2.71 Cr | ₹3.62 Cr | ₹3.27 Cr | ₹2.92 Cr | ₹1.21 Cr | ₹3.41 Cr | ₹3.98 Cr |
| attributable to NCI | ₹54,000 | ₹39,000 | ₹63,000 | ₹61,000 | ₹60,000 | ₹21,000 | ₹63,000 | ₹59,000 |
| Other Comprehensive Income | ₹7.36 Lakh | ₹18.6 Lakh | ₹0 | ₹0 | ₹76,000 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹2.26 Cr | ₹2.9 Cr | ₹3.62 Cr | ₹3.27 Cr | ₹2.93 Cr | ₹1.21 Cr | ₹3.41 Cr | ₹3.99 Cr |
| EBITDA (computed) | ₹6.88 Cr | ₹7.82 Cr | ₹8.71 Cr | ₹7.62 Cr | ₹7.06 Cr | ₹4.46 Cr | ₹8.19 Cr | ₹8.73 Cr |
| Basic EPS | ₹1.90 | ₹2.37 | ₹3.15 | ₹2.85 | ₹2.55 | ₹1.06 | ₹2.97 | ₹3.47 |
| Diluted EPS | ₹1.90 | ₹2.37 | ₹3.15 | ₹2.85 | ₹2.55 | ₹1.06 | ₹2.97 | ₹3.47 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹6.63 Cr | ₹7.02 Cr | ₹7.44 Cr | ₹7.47 Cr | ₹7.15 Cr | ₹2.37 Cr | ₹7.68 Cr | ₹6.49 Cr |
| Other Income | ₹2.37 Cr | ₹70.95 Lakh | ₹53.5 Lakh | ₹37.08 Lakh | ₹16.16 Lakh | ₹6.51 Lakh | ₹41.58 Lakh | ₹51.21 Lakh |
| Total Income | ₹8.99 Cr | ₹7.73 Cr | ₹7.98 Cr | ₹7.84 Cr | ₹7.31 Cr | ₹2.44 Cr | ₹8.1 Cr | ₹7 Cr |
| Cost of Materials Consumed | ₹1.32 Cr | ₹1.1 Cr | ₹2.32 Cr | ₹1.65 Cr | ₹1.9 Cr | ₹28.39 Lakh | ₹2.61 Cr | ₹2.35 Cr |
| Purchases of Stock-in-Trade | ₹1.46 Cr | ₹1.77 Cr | ₹68.34 Lakh | ₹1.83 Cr | ₹1.48 Cr | ₹1.17 Cr | ₹1.71 Cr | ₹83.09 Lakh |
| Changes in Inventories | ₹26.13 Lakh | ₹13.25 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹93.71 Lakh | ₹90.2 Lakh | ₹73.64 Lakh | ₹55.21 Lakh | ₹51.78 Lakh | ₹44.72 Lakh | ₹51.34 Lakh | ₹45.09 Lakh |
| Finance Costs | ₹3.31 Lakh | ₹2.39 Lakh | ₹14.1 Lakh | ₹24.9 Lakh | ₹70.54 Lakh | ₹83 Lakh | ₹1.38 Cr | ₹1.08 Cr |
| Depreciation & Amortisation | ₹6.48 Lakh | ₹6.34 Lakh | ₹5.83 Lakh | ₹6.78 Lakh | ₹4.47 Lakh | ₹4.4 Lakh | ₹4.38 Lakh | ₹4.84 Lakh |
| Other Expenses | ₹4.23 Cr | ₹1.88 Cr | ₹1.59 Cr | ₹1.87 Cr | ₹1.88 Cr | ₹91.22 Lakh | ₹2.32 Cr | ₹2.75 Cr |
| Total Expenses | ₹8.31 Cr | ₹5.87 Cr | ₹5.53 Cr | ₹6.22 Cr | ₹6.53 Cr | ₹3.69 Cr | ₹8.57 Cr | ₹7.51 Cr |
| Profit Before Exceptional Items & Tax | ₹68.19 Lakh | ₹1.86 Cr | ₹2.45 Cr | ₹1.63 Cr | ₹77.98 Lakh | -₹1.25 Cr | -₹47.2 Lakh | -₹50.84 Lakh |
| Exceptional Items | -₹3.49 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹64.7 Lakh | ₹1.86 Cr | ₹2.45 Cr | ₹1.63 Cr | ₹77.98 Lakh | -₹1.25 Cr | -₹47.2 Lakh | -₹50.84 Lakh |
| Total Tax Expense | -₹24.05 Lakh | ₹46.35 Lakh | ₹62.34 Lakh | ₹42.23 Lakh | ₹23.83 Lakh | -₹12.31 Lakh | ₹1.53 Cr | ₹31.9 Lakh |
| Net Profit | ₹88.75 Lakh | ₹1.39 Cr | ₹1.82 Cr | ₹1.2 Cr | ₹54.15 Lakh | -₹1.13 Cr | -₹2 Cr | -₹82.74 Lakh |
| Other Comprehensive Income | -₹98,000 | -₹53,000 | -₹2.42 Lakh | -₹5.08 Lakh | -₹2.14 Lakh | ₹2.29 Lakh | ₹33,000 | -₹2,000 |
| Total Comprehensive Income | ₹87.77 Lakh | ₹1.39 Cr | ₹1.8 Cr | ₹1.15 Cr | ₹52.01 Lakh | -₹1.11 Cr | -₹2 Cr | -₹82.76 Lakh |
| EBITDA (computed) | ₹77.98 Lakh | ₹1.95 Cr | ₹2.65 Cr | ₹1.94 Cr | ₹1.53 Cr | -₹37.96 Lakh | ₹95.03 Lakh | ₹61.96 Lakh |
| Basic EPS | ₹0.77 | ₹1.21 | ₹1.59 | ₹1.09 | ₹0.64 | ₹-1.33 | ₹-2.36 | ₹-0.97 |
| Diluted EPS | ₹0.77 | ₹1.21 | ₹1.59 | ₹1.09 | ₹0.64 | ₹-1.33 | ₹-2.36 | ₹-0.97 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹24.6 Cr | ₹24.72 Cr | ₹22.24 Cr | ₹21.37 Cr | ₹23.53 Cr | ₹17.64 Cr | ₹18.65 Cr | ₹20.41 Cr |
| Non-current Assets | ₹10.42 Cr | ₹10.46 Cr | ₹10.58 Cr | ₹11.13 Cr | ₹11.64 Cr | ₹11.95 Cr | ₹11.71 Cr | ₹13.29 Cr |
| Current Assets | ₹11.82 Cr | ₹10.69 Cr | ₹8.04 Cr | ₹6.5 Cr | ₹8.16 Cr | ₹1.95 Cr | ₹3.2 Cr | ₹3.39 Cr |
| Property, Plant & Equipment | ₹39.13 Lakh | ₹42.51 Lakh | ₹48.77 Lakh | ₹42.53 Lakh | ₹44.16 Lakh | ₹48.63 Lakh | ₹53.02 Lakh | ₹57.22 Lakh |
| Inventories | ₹80.17 Lakh | ₹78.3 Lakh | ₹90.11 Lakh | ₹57.57 Lakh | ₹79.49 Lakh | ₹57.98 Lakh | ₹15.05 Lakh | ₹41.77 Lakh |
| Trade Receivables | ₹41.86 Lakh | ₹84.52 Lakh | ₹59.44 Lakh | ₹1.08 Cr | ₹1.86 Cr | ₹43.26 Lakh | ₹2.06 Cr | ₹2.5 Cr |
| Cash & Equivalents | ₹32.15 Lakh | ₹50.34 Lakh | ₹43.97 Lakh | ₹1.27 Cr | ₹4.33 Cr | ₹10.17 Lakh | ₹10.79 Lakh | -₹52.99 Lakh |
| Equity (Net Worth) | ₹23.42 Cr | ₹22.54 Cr | ₹21.15 Cr | ₹19.35 Cr | ₹12.75 Cr | ₹4.71 Cr | ₹5.82 Cr | ₹7.82 Cr |
| Equity Share Capital | ₹11.49 Cr | ₹11.49 Cr | ₹11.49 Cr | ₹11.49 Cr | ₹9.81 Cr | ₹8.5 Cr | ₹8.5 Cr | ₹8.5 Cr |
| Borrowings (Non-current) | ₹16.28 Lakh | ₹40.66 Lakh | ₹0 | ₹16.08 Lakh | ₹1.15 Cr | ₹1.89 Cr | ₹2.77 Cr | ₹8.33 Cr |
| Borrowings (Current) | ₹0 | ₹0 | ₹0 | ₹91.07 Lakh | ₹8.05 Cr | ₹8.78 Cr | ₹8.03 Cr | ₹2.27 Cr |
| Total Debt (computed) | ₹16.28 Lakh | ₹40.66 Lakh | ₹0 | ₹1.07 Cr | ₹9.2 Cr | ₹10.67 Cr | ₹10.8 Cr | ₹10.6 Cr |
| Current Liabilities | ₹99.61 Lakh | ₹1.74 Cr | ₹1.06 Cr | ₹1.84 Cr | ₹9.63 Cr | ₹11.03 Cr | ₹10.04 Cr | ₹4.24 Cr |
| Total Liabilities | ₹1.18 Cr | ₹2.17 Cr | ₹1.08 Cr | ₹2.01 Cr | ₹10.78 Cr | ₹12.93 Cr | ₹12.83 Cr | ₹12.58 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | -₹72.05 Lakh | ₹27.91 Lakh | ₹8.36 Lakh | -₹28.16 Lakh | -₹36.02 Lakh |
| Investing Cash Flow | ₹57.16 Lakh | -₹19.15 Lakh | ₹30.21 Lakh | ₹13.77 Lakh | ₹0 |
| Financing Cash Flow | -₹3.3 Lakh | -₹2.39 Lakh | -₹1.21 Cr | -₹2.92 Cr | ₹4.59 Cr |
| Capital Expenditure | ₹3.1 Lakh | ₹0 | ₹12.06 Lakh | ₹5.19 Lakh | ₹0 |
| Free Cash Flow (computed) | -₹75.15 Lakh | ₹27.91 Lakh | -₹3.7 Lakh | -₹33.35 Lakh | -₹36.02 Lakh |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹18.19 Lakh | ₹6.37 Lakh | -₹82.67 Lakh | -₹3.07 Cr | ₹4.23 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹24.83 Lakh | ₹2.71 Cr | ₹1.7 Cr | ₹1.97 Cr | ₹83.7 Lakh | ₹98.63 Lakh | ₹1.54 Cr | ₹3.66 Cr |
| Other Income | ₹1.76 Cr | ₹21.97 Lakh | ₹19.67 Lakh | ₹18.69 Lakh | ₹18.93 Lakh | ₹16.67 Lakh | ₹18.07 Lakh | ₹17.28 Lakh |
| Total Income | ₹2.01 Cr | ₹2.93 Cr | ₹1.9 Cr | ₹2.15 Cr | ₹1.03 Cr | ₹1.15 Cr | ₹1.72 Cr | ₹3.83 Cr |
| Cost of Materials Consumed | ₹17.83 Lakh | ₹51.22 Lakh | ₹46.36 Lakh | ₹17.05 Lakh | ₹40,000 | ₹36.67 Lakh | ₹50.67 Lakh | ₹22.09 Lakh |
| Purchases of Stock-in-Trade | ₹0 | ₹25.93 Lakh | ₹23.77 Lakh | ₹96 Lakh | ₹90.09 Lakh | ₹6.77 Lakh | ₹18.38 Lakh | ₹1.11 Cr |
| Changes in Inventories | -₹6.72 Lakh | ₹20.59 Lakh | -₹10.18 Lakh | ₹22.45 Lakh | -₹36.04 Lakh | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹22.62 Lakh | ₹27.76 Lakh | ₹22.51 Lakh | ₹20.82 Lakh | ₹22.39 Lakh | ₹25.27 Lakh | ₹21.55 Lakh | ₹20.99 Lakh |
| Finance Costs | ₹61,000 | ₹18,000 | ₹1.54 Lakh | ₹98,000 | ₹50,000 | ₹97,000 | ₹20,000 | ₹72,000 |
| Depreciation & Amortisation | ₹1.6 Lakh | ₹1.63 Lakh | ₹1.67 Lakh | ₹1.58 Lakh | ₹1.57 Lakh | ₹1.59 Lakh | ₹1.6 Lakh | ₹1.58 Lakh |
| Other Expenses | ₹2.92 Cr | ₹68.19 Lakh | ₹37.96 Lakh | ₹25.17 Lakh | ₹34.91 Lakh | ₹23.47 Lakh | ₹43.11 Lakh | ₹86.55 Lakh |
| Total Expenses | ₹3.28 Cr | ₹1.96 Cr | ₹1.24 Cr | ₹1.84 Cr | ₹1.14 Cr | ₹94.74 Lakh | ₹1.36 Cr | ₹2.43 Cr |
| Profit Before Exceptional Items & Tax | -₹1.27 Cr | ₹97.29 Lakh | ₹66.15 Lakh | ₹31.39 Lakh | -₹11.19 Lakh | ₹20.56 Lakh | ₹36.14 Lakh | ₹1.4 Cr |
| Exceptional Items | -₹1.33 Lakh | -₹2.16 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹1.28 Cr | ₹95.13 Lakh | ₹66.15 Lakh | ₹31.39 Lakh | -₹11.19 Lakh | ₹20.56 Lakh | ₹36.14 Lakh | ₹1.4 Cr |
| Total Tax Expense | -₹72.98 Lakh | ₹24.22 Lakh | ₹16.81 Lakh | ₹7.9 Lakh | -₹2.83 Lakh | ₹4.78 Lakh | ₹9.09 Lakh | ₹35.31 Lakh |
| Net Profit | -₹54.99 Lakh | ₹70.91 Lakh | ₹49.34 Lakh | ₹23.49 Lakh | -₹8.36 Lakh | ₹15.78 Lakh | ₹27.05 Lakh | ₹1.05 Cr |
| Other Comprehensive Income | ₹49,000 | -₹1.47 Lakh | ₹0 | ₹0 | -₹53,000 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | -₹54.5 Lakh | ₹69.44 Lakh | ₹49.34 Lakh | ₹23.49 Lakh | -₹8.89 Lakh | ₹15.78 Lakh | ₹27.05 Lakh | ₹1.05 Cr |
| EBITDA (computed) | -₹1.24 Cr | ₹99.1 Lakh | ₹69.36 Lakh | ₹33.95 Lakh | -₹9.12 Lakh | ₹23.12 Lakh | ₹37.94 Lakh | ₹1.43 Cr |
| Basic EPS | ₹-0.48 | ₹0.62 | ₹0.43 | ₹0.20 | ₹-0.07 | ₹0.14 | ₹0.24 | ₹0.91 |
| Diluted EPS | ₹-0.48 | ₹0.62 | ₹0.43 | ₹0.20 | ₹-0.07 | ₹0.14 | ₹0.24 | ₹0.91 |
Shareholding Pattern of Parnax Lab Limited
As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 72.30%, retail and other public shareholders hold 27.70% of Parnax Lab Limited. The company had 3,721 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 72.30% | 72.30% | 72.30% | 72.30% | 72.30% | 72.30% |
| Public | 27.70% | 27.70% | 27.70% | 27.70% | 27.70% | 27.70% |
| Mar 2026 | Mar 2025 | Mar 2024 | |
|---|---|---|---|
| Promoters | 72.30% | 72.30% | 72.30% |
| Public | 27.70% | 27.70% | 27.70% |
| Promoter change (YoY, %pts) | +0.00 | +0.00 | - |
Group Structure of Parnax Lab Limited
Parnax Lab Limited has 1 subsidiary company. This group structure data is as of FY 2023. The corporate group structure reflects Parnax Lab Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Naxpar Pharma Private Limited | U52310MH2004PTC144449 | - |
Showing major subsidiaries. Total: 1.
Charges & Borrowings of Parnax Lab Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Sep 2002 | State Bank of India | ₹10.39 Cr | Open |
| 30 Mar 2000 | State Bank of India | ₹2.72 Cr | Open |
| 30 Mar 2000 | State Bank of India | ₹10.39 Cr | Open |
| 04 May 1995 | State Bank of India | ₹26 Lakh | Open |
| 04 May 1995 | State Bank of India | ₹26 Lakh | Open |
Total charge records: 9 View all charges
Employees and EPFO Compliance at Parnax Lab Limited
View historical data on people associated with Parnax Lab Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Parnax Lab Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Parnax Lab Limited
GSTIN & GST Filing Data of Parnax Lab Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Parnax Lab Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Parnax Lab Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Parnax Lab Limited
MSME Payment Delays by Parnax Lab Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Parnax Lab Limited
Subsidiaries & Group Companies of Parnax Lab Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Parnax Lab Limited with ownership details.
MCA Filings & Documents of Parnax Lab Limited
MCA Filings & Documents of Parnax Lab Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Parnax Lab Limited
Frequently Asked Questions about Parnax Lab Limited
Parnax Lab Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 03 August 1982 (44+ years old) and is registered under CIN L36912MH1982PLC027925. Listed on BSE: 506128.
Parnax Lab Limited reported revenue of ₹189.41 Cr for FY 2025 (up 0.00% YoY).
The current directors of Parnax Lab Limited are:
- Vijaykumar Shivaji Ayare
- Harish Sunderlal Panpalia
- Mihir Prakash Shah
- Yogesh Kantilal Varia
- Preet Vijay Kukreja
- Tirunillai Venkateswara Anatharaman
- Binoy Baiju Shah
- Ami Mihir Shah
- Mihir Prakash Shah
- Binoy Baiju Shah
The primary industry of Parnax Lab Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Yes. Parnax Lab Limited is listed on BSE with code 506128.
Parnax Lab Limited can be reached at the registered office: Gala No. 114 Bldg. No. 8 Jogani Industrial Complex Chunabhatti, Mumbai, Maharashtra, India – 400022, or through the website naxparlab.com.